Table: Chordia Therapeutics - Q1 parent results

Chordia Therapeutics

14/01/2025 24:00

Jan 14 (Reuters)- 
             Chordia Therapeutics Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Nov 30, 2024        Nov 30, 2023      Aug 31, 2025  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Operating     loss 624 mln                            loss 2.43   
  Recurring     loss 615 mln                            loss 2.38   
  Net           loss 616 mln                            loss 2.38   
  EPS           loss 9.07 yen                        loss 35.17 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Chordia Therapeutics Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T